Search Within

Yelena Yuriy Janjigian

Formats
  1. Meeting Abstract (219)
  2. Journal Article (157)
  3. Review (11)
  4. Editorial (6)
  5. Book Section (3)
  6. Guidelines (2)
  7. Research Letter (2)
  8. Conference Paper (1)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (403)
  2. Gastrointestinal Oncology Service (403)
  3. Solid Tumor Oncology Division (403)
  4. Center for Pancreatic Cancer Research (161)
  5. Surgery (149)
  6. Department of Pathology and Laboratory Medicine (137)

More Groups

People
  1. David Ilson (112)
  2. Geoffrey Ku (110)
  3. Laura Tang (84)
  4. David Kelsen (74)
  5. Daniela Molena (65)
  6. Steven Maron (65)

More People

Years
  1. 2025 (23)
  2. 2024 (33)
  3. 2023 (42)
  4. 2022 (37)
  5. 2021 (54)
  6. 2020 (23)

More Years

Publications
  1. Journal of Clinical Oncology (146)
  2. Annals of Oncology (46)
  3. Annals of Surgical Oncology (14)
  4. Annals of Surgery (13)
  5. Clinical Cancer Research (13)
  6. Oncology Research and Treatment (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (152)
  2. Oxford University Press (53)
  3. American Association for Cancer Research (28)
  4. Springer (22)
  5. Elsevier Inc. (19)
  6. Elsevier Science, Inc. (17)

More Publishers

Results (403)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer - A randomized, double-blind, placebo-controlled, phase 3 study
    Meeting Abstract

    Janjigian, Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z.; Al-Batran, S. E.; Hyung, W. J.; Molena, D.; Evans, B.; Ruscica, D.; Robbins, S. H.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03
    Meeting Abstract

    Stein, A.; Lordick, F.; Janjigian, Y. Y.; Oh, D. Y.; Lee, K. W.; Steeghs, N.; Chao, Y.; DI Bartolomeo, M.; Garcia, M. D.; Mohammad, N. H.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • First-line lenvatinib (Len) plus pembrolizumab (Pembro) plus chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in
    Meeting Abstract

    Shitara, K.; Ben-Aharon, I.; Rojas, C.; Eyzaguirre, D. A. A.; Hubert, A.; Moya, H. A.; Cohen, D.; Bai, L. Y.; Ghiringhelli, F.; Wyrwicz, L.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Dosiseskalations- und dosiserweiterungsstudie mit trastuzumab-deruxtecan(T-DXd)-monotherapie und -Kombinationen bei patienten mit fortgeschrittenem/ metastasiertem HER2+-magenkarzinom (GC) / adenokarzinom des gastroösophagealen überganges (GEJA): DESTINY-Gastric03
    Meeting Abstract

    Lordick, F.; Janjigian, Y. Y.; Oh, D. Y.; Rha, S. Y.; Lee, K. W.; Steeghs, N.; Chao, Y.; Di Bartolomeo, M.; Díez García, M.; Haj Mohammad, N.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma: Final results
    Meeting Abstract

    Cowzer, D.; Wu, A. J. C.; Sihag, S.; Walch, H. S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
    Journal Article

    Murciano-Goroff, Y. R.; Schram, A. M.; Rosen, E. Y.; Won, H.; Gong, Y.; Noronha, A. M.; Janjigian, Y. Y.; Stadler, Z. K.; Chang, J. C.; Yang, S. R.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Survival after trimodality therapy in patients with locally advanced esophagogastric adenocarcinoma: Does only a complete pathologic response matter?
    Journal Article

    Sihag, S.; Nobel, T.; Hsu, M.; De La Torre, S.; Tan, K. S.; Janjigian, Y. Y.; Ku, G. Y.; Tang, L. H.; Wu, A. J.; Maron, S. B.; more...
    Annals of Surgery (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade and targeted therapies in esophageal cancer
    Review

    Yang, J.; Janjigian, Y. Y.
    Thoracic Surgery Clinics (2022)

    Fulltext@MSK | Save
  • FOLFOX-based chemoradiation as non-operative management for esophageal adenocarcinoma
    Meeting Abstract

    Rouf, R.; Ku, G.; Cowzer, D.; Harrington, C.; Maron, S.; Janjigian, Y.; Ilson, D. H.; Molena, D.; Sihag, S.; Hajj, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save